Inspire Settles AzaSite False Marking Suit
Inspire Pharmaceuticals Inc. has agreed to pay Pharmaceutical Technologies LLC and the U.S. government a total of $150,000 to resolve a suit alleging it advertised eye infection treatment AzaSite with patents...To view the full article, register now.
Already a subscriber? Click here to view full article